Advertisement
Screener

Voyager Therapeutics, Inc. (VYGR) Net Margin

Voyager Therapeutics, Inc. (VYGR) Net Margin

  • 2026-06-30: Net Margin -773.24%.
  • 2026-03-31: Net Margin -1077.40%.
  • 2025-12-31: Net Margin -178.83%.
  • 2025-09-30: Net Margin -208.69%.

Complete source-backed net margin history.

Available history
2015-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-773.24%
2026-03-31-1077.40%
2025-12-31-178.83%
2025-09-30-208.69%
2025-06-30-641.96%
2025-03-31-479.24%
2024-12-31-549.33%
2024-09-30-36.72%
2024-06-30-34.29%
2024-03-31-58.05%
2023-12-3162.62%
2023-09-30-561.36%
2023-06-30-457.61%
2023-03-3182.43%
2022-12-311524.26%
2022-09-3042.90%
2022-06-30-2680.76%
2022-03-31-3239.97%
2021-12-3120.34%
2021-09-30-1696.15%
2021-06-30-2219.60%
2021-03-31-333.01%
2020-12-31-243.63%
2020-09-3072.65%
2020-06-30-30.27%
2020-03-31-134.29%
2019-12-31-38.48%
2019-09-30-73.44%
2019-06-3024.20%
2019-03-31-522.80%
2018-12-31-1122.06%
2018-09-30-968.91%
2018-06-30-991.88%
2018-03-31-2115.29%
2017-12-31-186.43%
2017-09-30-2033.62%
2017-06-30-1603.74%
2017-03-31-1137.16%
2016-12-31-621.21%
2016-09-30-271.95%
2016-06-30-250.94%
2016-03-31-148.82%
2015-12-31-147.52%
2015-09-30-79.34%
2015-06-30-79.75%
2015-03-31-565.88%

Annual Net Margin

DateNet Margin
2025-12-31-296.53%
2024-12-31-81.25%
2023-12-3152.93%
2022-12-31-113.45%
2021-12-31-190.29%
2020-12-3121.47%
2019-12-31-41.76%
2018-12-31-1158.79%
2017-12-31-697.56%
2016-12-31-282.65%
2015-12-31-171.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79